112 related articles for article (PubMed ID: 38547657)
21. Multi-omics cluster defines the subtypes of CRC with distinct prognosis and tumor microenvironment.
Ma Y; Li J; Zhao X; Ji C; Hu W; Ma Y; Qu F; Sun Y; Zhang X
Eur J Med Res; 2024 Mar; 29(1):207. PubMed ID: 38549156
[TBL] [Abstract][Full Text] [Related]
22. Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.
Shen C; Zhang S; Zhang Z; Yang S; Zhang Y; Lin Y; Fu C; Li Z; Wu Z; Wang Z; Li Z; Guo J; Li P; Hu H
Funct Integr Genomics; 2023 Jun; 23(3):211. PubMed ID: 37358720
[TBL] [Abstract][Full Text] [Related]
23. PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma.
Wang J; Wu N; Feng X; Liang Y; Huang M; Li W; Hou L; Yin C
Front Immunol; 2022; 13():1052692. PubMed ID: 36685506
[TBL] [Abstract][Full Text] [Related]
24. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
25. The role of APOBEC3C in modulating the tumor microenvironment and stemness properties of glioma: evidence from pancancer analysis.
Zhang S; Guo Y; Hu Y; Gao X; Bai F; Ding Q; Hou K; Wang Z; Sun X; Zhao H; Qu Z; Xu Q
Front Immunol; 2023; 14():1242972. PubMed ID: 37809064
[TBL] [Abstract][Full Text] [Related]
26. CREB5 promotes cell proliferation and correlates with poor prognosis in hepatocellular carcinoma.
Wu J; Wang ST; Zhang ZJ; Zhou Q; Peng BG
Int J Clin Exp Pathol; 2018; 11(10):4908-4916. PubMed ID: 31949566
[TBL] [Abstract][Full Text] [Related]
27. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA SNHG4 promotes the malignant progression of hepatocellular carcinoma through the miR-211-5p/CREB5 axis.
Qiu J; Wang P; Chen Z; Zhou Y; Zhang G; Wang Z; Wu J; Zhu Q; Jiang C
Cancer Med; 2023 Apr; 12(7):8388-8402. PubMed ID: 36565037
[TBL] [Abstract][Full Text] [Related]
29. TRIM56: a promising prognostic immune biomarker for glioma revealed by pan-cancer and single-cell analysis.
Wang B; Wang Z; Li Y; Shang Z; Liu Z; Fan H; Zhan R; Xin T
Front Immunol; 2024; 15():1327898. PubMed ID: 38348047
[TBL] [Abstract][Full Text] [Related]
30. Low-density lipoprotein receptor promotes crosstalk between cell stemness and tumor immune microenvironment in breast cancer: a large data-based multi-omics study.
Yuan Q; Lu X; Guo H; Sun J; Yang M; Liu Q; Tong M
J Transl Med; 2023 Nov; 21(1):871. PubMed ID: 38037058
[TBL] [Abstract][Full Text] [Related]
31.
Qu S; Liu J; Wang H
Front Immunol; 2021; 12():648416. PubMed ID: 33889156
[TBL] [Abstract][Full Text] [Related]
32. CREB5 promotes tumor cell invasion and correlates with poor prognosis in epithelial ovarian cancer.
He S; Deng Y; Liao Y; Li X; Liu J; Yao S
Oncol Lett; 2017 Dec; 14(6):8156-8161. PubMed ID: 29250192
[TBL] [Abstract][Full Text] [Related]
33. Integrative analysis unveils ECM signatures and pathways driving hepatocellular carcinoma progression: A multi-omics approach and prognostic model development.
Liu Z; Zhao P
J Cell Mol Med; 2024 Apr; 28(8):e18230. PubMed ID: 38568083
[TBL] [Abstract][Full Text] [Related]
34. Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.
Tu Z; Ouyang Q; Long X; Wu L; Li J; Zhu X; Huang K
Front Immunol; 2022; 13():837512. PubMed ID: 35401558
[TBL] [Abstract][Full Text] [Related]
35. Multi-omics approaches establishing histone modification based prognostic model in glioma patients and further verification of the carcinogenesis mechanism.
Wang Y; Ji L; Ji C; Wang F
Funct Integr Genomics; 2023 Sep; 23(4):307. PubMed ID: 37730879
[TBL] [Abstract][Full Text] [Related]
36. PTPN1 is a prognostic biomarker related to cancer immunity and drug sensitivity: from pan-cancer analysis to validation in breast cancer.
Zhao R; Chen S; Cui W; Xie C; Zhang A; Yang L; Dong H
Front Immunol; 2023; 14():1232047. PubMed ID: 37936713
[TBL] [Abstract][Full Text] [Related]
37. Prognostic and immunomodulatory roles of schizophrenia-associated genes HTR2A, COMT, and PRODH in pan-cancer analysis and glioma survival prediction model.
Shen J; Wang Q; Lu F; Xu H; Wang P; Feng Y
Front Immunol; 2023; 14():1201252. PubMed ID: 37564635
[TBL] [Abstract][Full Text] [Related]
38. Circular RNA circVAPA knockdown suppresses colorectal cancer cell growth process by regulating miR-125a/CREB5 axis.
Zhang X; Xu Y; Yamaguchi K; Hu J; Zhang L; Wang J; Tian J; Chen W
Cancer Cell Int; 2020; 20():103. PubMed ID: 32256212
[TBL] [Abstract][Full Text] [Related]
39. Integrative analysis revealed a correlation of PIAS family genes expression with prognosis, immunomodulation and chemotherapy.
Zhang Q; Zhang J; Lan T; He J; Lei B; Wang H; Mei Z; Lv C
Eur J Med Res; 2024 Mar; 29(1):195. PubMed ID: 38528630
[TBL] [Abstract][Full Text] [Related]
40. Plasma microRNA-320c as a Potential Biomarker for the Severity of Knee Osteoarthritis and Regulates cAMP Responsive Element Binding Protein 5 (CREB5) in Chondrocytes.
Zhou R; Zhao L; Wang Q; Cheng Y; Song M; Huang C
Dis Markers; 2024; 2024():9936295. PubMed ID: 38549717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
